citric acid, anhydrous + magnesium oxide light + sodium picosulfate: prescribing and clinical use
Focused clinical detail for use alongside current product information, local policy and patient-specific assessment.
citric acid, anhydrous + magnesium oxide light + sodium picosulfate: clinical details
Prescribing considerations
- Confirm that bowel cleansing is clinically required; this product is not a routine laxative.
- Assess frailty, low body weight, age, recent gastrointestinal surgery, renal or cardiac disease, inflammatory bowel disease and medicines affecting fluid or electrolytes.
- Review oral medicines whose absorption is clinically critical, including antiepileptics, contraceptives and diabetes treatments.
- Give explicit instructions on permitted clear liquids and warn against replacing losses with water alone.
Contraindications and cautions
- Hypersensitivity to an ingredient; congestive cardiac failure; gastric retention or gastrointestinal ulceration.
- Ileus, toxic colitis, toxic megacolon, active inflammatory bowel disease, or known or suspected gastrointestinal obstruction or perforation.
- Nausea and vomiting, acute surgical abdominal conditions, severe dehydration, rhabdomyolysis or hypermagnesaemia.
- Severely reduced renal function because magnesium may accumulate; select another preparation.
Monitoring
- Consider hydration status, renal function and electrolytes in patients at increased risk.
- Watch for hypokalaemia, hyponatraemia or hypermagnesaemia, particularly in frail patients or those taking interacting medicines.
- Ensure reliable management of medicines with narrow therapeutic consequences if absorption is reduced.
Clinical pharmacology
Sodium picosulfate is activated by colonic bacteria and stimulates the colonic and rectal mucosa. Magnesium citrate acts osmotically by retaining fluid in the colon. Both components act locally, with no detectable systemic absorption reported in the SmPC.
Formulation and product differences
- The product is an orange-flavoured powder for oral solution supplied in sachets.
- The flavour contains lactose; the preparation also contains potassium hydrogen carbonate and saccharin sodium.
- A measuring spoon is included for clinician-directed paediatric preparation.
citric acid, anhydrous + magnesium oxide light + sodium picosulfate interactions
Rapid bowel transit, diarrhoea and magnesium can alter the absorption or effects of other medicines.
Oral medicines, including antiepileptics, contraceptives, antidiabetics and antibiotics
Absorption may be reduced; ask the procedure team whether administration needs adjusting.
Tetracycline or fluoroquinolone antibiotics, iron, digoxin, chlorpromazine and penicillamine
Magnesium can bind these medicines and reduce absorption. A clinician or pharmacist should direct appropriate separation.
Diuretics, corticosteroids and cardiac glycosides
Fluid loss or low potassium may be more likely or more clinically important.
Sources
These sources were used to prepare and review this medicine page.
Prepared and reviewed by the iatroX editorial team.